Fluorescence‐based discrimination of breast cancer cells by direct exposure to 5‐aminolevulinic acid

Protoporphyrin IX‐fluorescence measurement is a powerful in situ approach for cancer detection after oral/topical administration of 5‐aminolevulinic acid. However, this approach has not been clinically established for breast cancer, probably due to insufficient delivery of 5‐aminolevulinic acid to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Midori, Tanaka, Hideo, Kumamoto, Yasuaki, Nakamura, Akihiro, Harada, Yoshinori, Ogata, Takehiro, Sakaguchi, Koichi, Taguchi, Tetsuya, Takamatsu, Tetsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746108/
https://www.ncbi.nlm.nih.gov/pubmed/31385432
http://dx.doi.org/10.1002/cam4.2466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746108/
https://www.ncbi.nlm.nih.gov/pubmed/31385432
http://dx.doi.org/10.1002/cam4.2466

Ejemplares similares